ENST00000598216.1:n.2240G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000598216.1(INSR):n.2240G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0311 in 1,571,264 control chromosomes in the GnomAD database, including 7,858 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.043   (  882   hom.,  cov: 31) 
 Exomes 𝑓:  0.030   (  6976   hom.  ) 
Consequence
 INSR
ENST00000598216.1 non_coding_transcript_exon
ENST00000598216.1 non_coding_transcript_exon
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.403  
Publications
10 publications found 
Genes affected
 INSR  (HGNC:6091):  (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015] 
INSR Gene-Disease associations (from GenCC):
- insulin-resistance syndrome type AInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- Donohue syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- hyperinsulinism due to INSR deficiencyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- Rabson-Mendenhall syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82). 
BP6
Variant 19-7152692-C-T is Benign according to our data. Variant chr19-7152692-C-T is described in ClinVar as Benign. ClinVar VariationId is 1269775.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.472  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| INSR | NM_000208.4 | c.2231+34G>A | intron_variant | Intron 10 of 21 | ENST00000302850.10 | NP_000199.2 | ||
| INSR | NM_001079817.3 | c.2231+34G>A | intron_variant | Intron 10 of 20 | NP_001073285.1 | |||
| INSR | XM_011527988.3 | c.2231+34G>A | intron_variant | Intron 10 of 21 | XP_011526290.2 | |||
| INSR | XM_011527989.4 | c.2231+34G>A | intron_variant | Intron 10 of 20 | XP_011526291.2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| INSR | ENST00000598216.1 | n.2240G>A | non_coding_transcript_exon_variant | Exon 10 of 10 | 1 | |||||
| INSR | ENST00000302850.10 | c.2231+34G>A | intron_variant | Intron 10 of 21 | 1 | NM_000208.4 | ENSP00000303830.4 | |||
| INSR | ENST00000341500.9 | c.2231+34G>A | intron_variant | Intron 10 of 20 | 1 | ENSP00000342838.4 | 
Frequencies
GnomAD3 genomes  0.0428  AC: 6499AN: 151976Hom.:  878  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
6499
AN: 
151976
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0837  AC: 20858AN: 249218 AF XY:  0.0725   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
20858
AN: 
249218
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0299  AC: 42399AN: 1419170Hom.:  6976  Cov.: 26 AF XY:  0.0288  AC XY: 20411AN XY: 708250 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
42399
AN: 
1419170
Hom.: 
Cov.: 
26
 AF XY: 
AC XY: 
20411
AN XY: 
708250
show subpopulations 
African (AFR) 
 AF: 
AC: 
103
AN: 
32612
American (AMR) 
 AF: 
AC: 
9994
AN: 
44656
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
223
AN: 
25900
East Asian (EAS) 
 AF: 
AC: 
20308
AN: 
39464
South Asian (SAS) 
 AF: 
AC: 
3455
AN: 
85250
European-Finnish (FIN) 
 AF: 
AC: 
2984
AN: 
53204
Middle Eastern (MID) 
 AF: 
AC: 
22
AN: 
4184
European-Non Finnish (NFE) 
 AF: 
AC: 
2835
AN: 
1075000
Other (OTH) 
 AF: 
AC: 
2475
AN: 
58900
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.484 
Heterozygous variant carriers
 0 
 1681 
 3361 
 5042 
 6722 
 8403 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 490 
 980 
 1470 
 1960 
 2450 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0428  AC: 6509AN: 152094Hom.:  882  Cov.: 31 AF XY:  0.0509  AC XY: 3784AN XY: 74334 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
6509
AN: 
152094
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
3784
AN XY: 
74334
show subpopulations 
African (AFR) 
 AF: 
AC: 
206
AN: 
41522
American (AMR) 
 AF: 
AC: 
2551
AN: 
15256
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
15
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
2498
AN: 
5118
South Asian (SAS) 
 AF: 
AC: 
265
AN: 
4814
European-Finnish (FIN) 
 AF: 
AC: 
638
AN: 
10602
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
267
AN: 
68000
Other (OTH) 
 AF: 
AC: 
68
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 231 
 463 
 694 
 926 
 1157 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 68 
 136 
 204 
 272 
 340 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
758
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.